Level C· Early human research exploring benefitsProspective StudyPubMedOpen access

Vasculogenic potential of adipose tissue derived stem cells from patients with chronic spinal cord injury and pressure injuries.

Santos-De-La-Mata Á., Esteban PF., Martínez-Torija M., Paniagua-Torija B., Espino-Rodríguez FJ., Beltrán-Camacho L.

Prospective Study on Spinal Cord Injury, Chronic Wound, published in Angiogenesis (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Angiogenesis (2025)
Country
Germany
Reported sample size
—
Source database
PubMed
PMID
40928671
PMCID
PMC12423250
DOI
10.1007/s10456-025-10002-y
Citations
3

Abstract (original English)

Limited vascularization and ischemia are major contributors to the chronicity of wounds, such as ulcers and traumatic injuries, which impose significant medical, social, and economic burdens. These challenges are particularly pronounced in patients with spinal cord injury (SCI), a disabling condition associated with vascular dysfunction, infections, and impaired peripheral circulation, complicating the treatment of pressure injuries (PIs) and the success of reconstructive procedures like grafts and flaps. Regenerative medicine aims to address these issues by identifying effective cellular therapies to restore vascular beds. Among these, cells from the stromal vascular fraction (SVF) of adipose tissue (AT) are promising due to their abundance of angiogenic and vasculogenic cells, including mesenchymal stem cells (MSCs) and endothelial colony-forming cells (ECFCs). This study evaluated the vasculogenic potential of AT-derived cellular fractions isolated via enzymatic digestion of white adipose tissue (WAT). We compared adipose-derived stem cells (ASCs) cultured from SVF with a combination of ECFCs and MSCs, expanded separately and transplanted in a 40:60 ratio. Results showed that while ASCs promote angiogenesis and vasculogenesis, the ECFC/MSC combination is superior, consistently forming perfused vascular beds in subcutaneous implants in nude mice. Furthermore, ECFCs and MSCs e

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Spinal Cord InjuriesHumansAnimalsNeovascularization, PhysiologicAdipose TissuePressure UlcerMiceMaleMesenchymal Stem CellsChronic Disease

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research